New Medical Breakthrough Could Save More Lives Than Penicillin And
End Disease As We Know It
Ex-Economics Professor uncovers the company that could be on the brink of erasing disease with ”custom coded cures“ that could add 40 pain-free years to your life… It may sound like science fiction, but this company is turning it into science FACT. The best part is, you could make millions with it.
Hi, Genia Turanova here, chief investment strategist at StreetAuthority.
In the next few minutes, you’re going to hear some news you’ll find hard to believe…
But as you digest the facts, and see all the proof… you will realize that we are on the verge of a true medical miracle.
It’s a breakthrough that will change our world more than cars, airplanes, antibiotics, the internet, or any other development of the past century.
And most people have no idea it is coming.
In fact, thanks to a stunning breakthrough in genetic research…
This real-life miracle will transform the very basics of health and medicine.
We haven’t seen a life-saving breakthrough on this scale since penicillin.
It will affect every American alive today. It’s that big.
Quite frankly, it changes everything.
And if you are over 50, it will impact your life in a deep and significant way…
Now let me ask you something personal…
How long do you expect to live? Until you’re 80, 90, or — if you’re lucky — 100?
Well, it’s time to think bigger than that. Because you’re off by two, three, maybe even four decades.
The Medical Device that Tells Death to Wait
You know all those promises about how one day scientists will eradicate disease… and how we’ll all live to be 120 and play golf every day?
Like flying cars, most of us dismissed it as a pipedream long ago.
But I’ve got news for you. It looks like this is actually going to happen after all.
And it might kick into gear before kids now in high school graduate college.
It’s all thanks to a disease-killing tool that’s faster, cheaper, and far more accurate than anything tried before.
Scientists call it genetic editing — personalized, precision medicine that repairs broken human DNA.
This is more than just another interesting medical breakthrough… it could bring about the end of hereditary disease.
This is huge. More than 6,000 medical disorders are caused by faulty, heritable DNA. These mutations give us heart disease, high blood pressure, Alzheimer’s, diabetes… and all the other killers that can run in the family.
Until now, the only thing you could do was hope you never come down with whatever you’re genetically disposed to.
If your father had high blood pressure… your grandfather… your uncle… all you could do was hope you did everything right and didn’t eventually get it yourself.
But now all that’s about to change — because a small group of scientists is figuring out a way to turn off the genes causing the problem.
And if this isn’t astonishing enough, genetic editing lets researchers repair faulty genes that are not inherited. That means that even most cancers, which are not inherited, could now be fixed through the use of this technology.
It’s mind-bending, Star Trek stuff. We’re already starting to see the first glimpse of what’s coming…
A Repair Shop for Broken DNA
Human DNA has about 20,000 genes. Each one is “set at the factory” to carry out a specific task, be it growth, healing, or signaling the body to respond to various stimuli.
If a gene becomes corrupted, these instructions are muddled and rendered useless. The genetic code has a typo, a flaw in the software, so to speak.
The solution isn’t easy, but it’s conceptually simple: Just fix the typo.
Now, I’ve found a small group of researchers in Switzerland who are doing just that. They’ve developed a biochemical process that acts as a tiny guillotine, cutting the DNA strand right at the point where an error has occurred.
The corrected DNA, doing what DNA naturally does, begins to replicate, ultimately correcting the gene — and the problem
The team is led by a biotech genius who personally holds five pharmaceutical patents.
After med school in Europe, he practiced in the United States, taught at Rockefeller University and worked at St. Jude’s Children’s Research Hospital.
He then started his pharmaceutical career at Novartis and was later a global head of R&D at Sanofi.
He has a long track record of translating technologies into pharmaceutical products. And his new company is quickly becoming the ruler of the realm in this novel technology.
Its gene-editing tool is going to be much simpler and easier to use than previous gene editors… and it’s 99% cheaper, too.
Beyond cancer, its research could lead to cures for Down syndrome, hemophilia, cystic fibrosis, muscular dystrophy, even color blindness.
But let’s start with cancer…
The reason it’s such a killer is that damaged, cancerous cells spread fast. But in order to spread they need to communicate with the cells around them.
But these researchers have found a way to prevent those cells from talking to one another… so they stop multiplying and die out.
Early results are remarkable…
It has completely wiped out some colon and kidney tumors and is now being tested against melanoma, breast, lung, ovarian, and other cancers.
This is obviously good news for anyone alive today. And for anyone they love. But for investors like me, it’s absolutely thrilling because…
One Company Is Already Benefiting From This Technology
This genetic editing tool is the sole property of this Swiss company.
Its proprietary technology will allow for precise, directed changes to DNA.
The opportunities are almost endless…
Scientists have used gene editing to remove HIV from a living organism.
By cutting and pasting, researchers created a cancer-busting gene that actually shrunk tumors in mice.
Gene editing has been used to force superbugs to kill themselves.
This approach has disabled the defective gene that triggers ALS in mice and extended their lifespan by 25%. And it has halted muscular dystrophy in dogs.
Researchers have deleted Huntington’s disease genes in mice, helping them regain their motor control and reversing signs of the fatal condition. It’s entirely likely that this technique could work on humans as well.
Another thing…
This company’s gene-editing platform is different from all the others because it has licensed the patents for human therapeutic use. In fact, it has already begun its first human trials.
When those new drugs complete their trials, they’ll head to an FDA that’s eager to investigate new medicines.
President Trump named Scott Gottlieb to head the Food and Drug Administration because he wanted to speed up the approval process.
And Gottlieb has been as good as his word when it comes to approving new treatments.
Last year, 46 got the nod, more than twice as many as were approved in the final year of the Obama administration.
The company I like so much is already posting surging sales — extremely rare for such a young biotech.
In 2015, its total revenue was roughly the combined pretax income of five schoolteachers — all of $250,000.
But in 2016, the top line shot to more than $5 million. And in 2017, it came in at $11.6 million, more than twice the previous year.
Revenue is surging because this is a technology the industry is clamoring for. Its balance sheet looks good, too, with $320 million in cash, sufficient to fund operations for years.
Not only are the company’s projects taking off, but so is the stock. It’s up 87% in the past year. But that’s nothing compared to what I see coming next.
This Is Medicine’s Logical Next Step
Step back and think about how far and how fast medicine has moved in the past 100 years or so.
As we closed out the 1800s, we barely had a handle on basic germ theory. When President Garfield was shot in 1881, it wasn’t the bullet that killed him but a massive infection introduced by a doctor’s unsterilized hands.
Following the devastating results of chemical warfare in World War I, doctors began studying nitrogen mustard as a cancer treatment. By the 1940s, the first generation of chemotherapy was used to treat children suffering from leukemia — previously an automatic death sentence.
The first successful organ transplant, a kidney, was in 1954.
The polio vaccine was developed in 1955. Thanks to Jonas Salk, more than 16 million people have been saved from paralysis.
Smallpox was eradicated by 1980, after killing 450 million people in the 20th century alone.
Scientists in Scotland cloned a sheep, named for Dolly Parton, just four years before the end of the millennium.
In 1997, GlaxoSmithKline introduced Combivir, the first of the AIDS cocktails that would eventually make the deadly virus a manageable condition.
In 2003, after a 13-year project, the human genome was sequenced, opening the door to the genetic editing we’re seeing today.
In what amounts to an eyeblink in the span of human history, we went from not knowing enough to wash our hands before surgery to the point where surgery might be obsolete.
Now, thanks to genetic editing, we are talking about ending killer diseases and opening up a wide range of other possibilities:
- A limitless supply of transplant organs
More than 100,000 Americans are waiting for organ transplants right now — and many will die waiting. Editing the genes of pigs could turn them into safe organ donors for humans. - Malaria-proof mosquitoes
Mosquitoes spread the malaria parasite, which kills hundreds of thousands of people a year. By deleting one of its genes, the parasite can’t survive long enough in the mosquito’s gut to hurt humans. - Super crops
By tricking plants into closing the pores that release water, genetic engineers are making crops 25% more water efficient — without affecting their yield. This could convert millions of acres of wasteland into verdant cropland and alleviate world hunger. They are also removing the genes that make potatoes and wheat vulnerable to disease… and developing tomato plants with branches strong enough to handle the weight of ripe tomatoes.
We’re at the Doorstep of Much Longer Lives
Genetic editing is bringing us to the doorstep of a colossal jump in our lifespans.
Over the next decade, survival rates will soar for dozens of diseases, just like we already have now with certain types of early-stage cancer.
The science is getting figured out. And the company I’m recommending is the closest of all to making it a reality.
For instance, just consider that every year, 600,000 people die of cancer in America. 1.2 million have a heart attack. 30 million are struggling with diabetes.
But with personalized medicine, that’s all about to change. Big time.
When we were growing up, breast cancer was a death sentence for most women.
But then came chemotherapy and radiation… it’s a painful regimen, but it saved the lives of millions of women. It’s still a scary diagnosis, but survival rates now are reaching 100% in most cases.
Now, we’ve taken another step. Scientists at Cambridge actually have identified the exact genes that cause breast cancer.
We’re inching toward the day when we will be able to get the cure but without the chemotherapy. And without the surgery.
That’s why personalized medicine, based on your individual genes, is starting to make old-line treatments like chemotherapy and surgery obsolete.
For example, researchers have developed a blood test that can replace mammograms. Amazingly, it can detect breast cancer five years in advance… that’s five years before it even starts developing.
So now you’re dealing with a situation where cancer can be detected so early that it never happens. You never get it!
And now, scientists are doing the same thing with diabetes… heart disease… Alzheimer’s… you name it.
Up to now, you got sick, you went to your doctor and got a prescription for medicine or a treatment that was made for everybody.
But very soon, your doctor will be able to run a simple blood test and find out what genes are causing the disease in your body. And you’ll be able to get a prescription that’s custom made for you.
For instance, we now know of 93 different genes that can cause breast cancer. Any combination of them can cause it — and the permutations run into the millions.
It’s different for every person. That’s why traditional medicine has never found a cure that’s worked for everyone.
But with personalized medicine, a doctor can find out exactly which one of the 93 genes is causing your disease. And then use medicine that only turns off that specific gene, nothing else. You take your tailor-made medicine, and your life goes on.
When you find a problem gene and turn it off, you head off problems before they even happen.
For instance, the FDA recently approved a drug that turns off one of the genes that causes blindness.
Imagine that you’re slowly going blind, and then someone comes along and gives you this medicine, and suddenly you can see again.
We’re not used to these kinds of miracles in medicine. But they’re becoming real.
Scientists are identifying which genes cause which disease. It’s only a matter of time before every major disease is nailed down and solved.
The thing is… people have a hard time believing it will happen. Disease is an intrinsic part of our lives and always has been. It’s hard to change that mindset. But these changes are happening regardless.
You have to remember that 100 years ago, the major killers weren’t heart disease or cancer but the flu and pneumonia.
Getting either one was pretty much a death sentence for many people. And nobody at the time would have thought any different.
But then Alexander Fleming discovered antibiotics in 1928, and presto… pneumonia was easily handled.
Today, the very same thing is happening with personalized medicine.
I know it’s hard to imagine a world without cancer or diabetes… heart disease or Alzheimer’s. But that’s where we’re headed. And I’m thrilled to be around for it.
Get Ready for a Third Life
The most obvious consequence of eliminating killer diseases is that people are going to live longer. A lot longer.
Over the next decade, we’re going to see life expectancy increase in a way it hasn’t changed since the discovery of antibiotics.
Throughout history, the human life span was short.
Until about 150 years ago, we lived to be about 40, on average.
It had been that way for thousands of years. And nobody thought it could be any different.
But antibiotics changed all that. Now we take it for granted that we’ll probably live until we’re about 80.
In other words, we used to get one life. Now we get two.
And with personalized medicine, we’re about to get a third.
We already know from accounts around the world that people can live for 120 years.
Japan, for instance, has more than 67,000 people over 100… most of them still with their wits about them, healthy and active. In 1971, there were just 339 centenarians in the entire country.
Living to 120 will become commonplace as personalized medicine unlocks these genes during the next decade.
And again, one single company stands alone at the forefront of this transformation.
How Investors Should Play This
As I told you up front, I’m a market strategist. That’s a fancy way of saying my job is to buy stocks before they go up.
But you could also say I’m an investment detective. I look for clues to the future, gather the evidence, and predict how our society will change.
Then I try to capitalize on my predictions by picking stocks that will benefit. I release my research in a service called Fast-Track Millionaire.
Today, I’ve laid out what I see coming in medicine. Of course, it won’t unroll exactly as I’m laying it out for you today, but that’s ok.
Even if you get a few details wrong, you can make a fortune as long as you get the big picture right.
Get in on a few key stocks at the start of a world-changing breakthrough like personalized medicine and you’re likely to count your returns in the thousands of percent.
Fast-Track Millionaire has already recommended more than 20 medical stocks that made their investors massive windfall profits.
Incyte developed a medication that turns off genes that cause blood cancer. It shot up 789% for us.
Esperion is headed by the scientist who invented the cholesterol-fighting drug Lipitor. His new cholesterol treatment takes advantage of personalized medicine and it’s a big reason the stock is up 580% since we featured it in Fast-Track Millionaire.
Ariad Pharmaceuticals created a drug to handle endometrial cancer, even when it wasn’t treatable with surgery or chemotherapy. It shot up 485% after we recommended it.
Exact Sciences shot up 544% thanks to its revolutionary cancer diagnostics technology.
DexCom, the diabetes specialist, gained 652%. One of our diabetic analysts actually tried their insulin pump as part of his research. He hooked up their product to his body and reported that it worked like a charm.
Disruptors Make Millionaires
Personalized medicine is going to spark a new wave of stock gains. It will create countless millionaires, but it will also disrupt conventional medicine… and hurt a lot of existing healthcare businesses.
Every industry has its disruptors. And they tend to make early investors massively rich.
Remember when video rentals was a big business? Blockbuster Video was the king of home movie renting. No one could compete with it.
Then, out of the blue, along comes Netflix, which single-handedly buried the whole video industry. All thanks to online streaming.
Sixteen years ago, Netflix IPO’d at $15 a share. Since then, it’s shot up 18,000% turning every $10,000 into $1.8 million.
We’re seeing the same thing start to happen with personalized medicine. These genetic breakthroughs are sparking mega-growth for a lot of companies.
I’m sure some will grow 18,000% just like Netflix did when it gave us a “better mousetrap” for home entertainment.
The first step to finding these winners is zeroing in on the right catalyst. You have to sift through a ton of information. It’s tedious research.
But I immerse myself in it and make sure I understand if there is an actual opportunity there. There is no other way. I look for breakout stocks in every industry.
By the time an opportunity is making headlines, I want to already be invested in it. Because that’s how you make the huge gains.
This is true with any industry, not just personalized medicine.
Take the shale oil boom following the discovery of horizontal drilling and fracking…
That was a bonanza for us at Fast-Track Millionaire. We landed shale oil stocks like U.S. Silica that shot up 580%, turning $10,000 into $68,500… and Cheniere Energy which rose 447%, turning $10,000 into $54,700.
By the way, none of the stock gains I’m talking about here are theoretical back tests.
They’re all actual recommendations that we’ve made. In writing. For everyone to see.
Anyone who invested when we made them could be sitting on these gains themselves.
The Biggest Call of My Career
I have devoted the past 17 years of my life to finding life-changing investing opportunities.
After teaching university economics for nine years, I went to Wall Street. I helped manage a multi-million dollar portfolio… and since joining StreetAuthority, I’ve been averaging a 49.9% annualized return. That blows the market’s 17.7% out of the water.
But this personalized medicine breakthrough based on genetic editing could be the biggest winner of my career. It’s the most lucrative opportunity I’ve ever seen.
I’m so sure of it, that I guarantee it will give you a chance to make 100% or more — the equivalent of turning every $10,000 into $20,000.
That’s right, I guarantee it.
Now, to anyone who doesn’t know me, this may seem like an empty promise.
But when you consider Fast-Track Millionaire’s record — it’s worth a deeper look.
My service has a history of uncovering trends early and capturing extraordinarily large profits as a result.
It’s how we zeroed in on Regeneron, which shot up 907%… turning $10,000 into $100,600. A 10-bagger.
And CalAmp, which took off 996%… growing a $10,000 stake into $109,000. Another 10-bagger.
And Alnylam Pharmaceuticals, which exploded 1,263%… turning every $10,000 invested into $136,000.
Most investors don’t get into opportunities like these until they see them on TV.
Fast-Track Millionaire subscribers got in before that. Way before.
For instance, today a lot of investors are talking about marijuana stocks.
Now that the laws are changing, everybody wants to get in on the action.
We already did that. Before the media and Wall Street started going nuts about it.
As soon as we realized the pot business had real potential, one of our researchers got on a plane and flew to Tokyo.
It’s probably the last place you would expect to find anything to do with cannabis investing. But Japan has some of the world’s most advanced agricultural technology. They have to. They have tons of people and little arable land.
We found an indoor farm that grows 100 times more produce per acre than a farmer in Iowa.
They do it without using any genetic manipulation. No harsh chemicals or fertilizers. No destructive farming techniques.
And the kicker is that they use 40% less power and 99% less water than a typical farmer.
It isn’t a stretch to see how this hyper-efficient technology could be exploited by any forward-thinking cannabis company.
One of the pot stocks we picked rose 574%…
Another shot up 335%.
Another 279%.
Now, we’re looking at a cannabis outfit that has developed a radical new technology to extract the medicinal ingredients from the plant.
Their process takes only 10 minutes — traditional methods can take hours.
Not only that, the traditional extraction methods — for cannabis, or any other plant for that matter — involve toxic solvents and chemicals.
But this company’s technique leaves no poisonous residue. It’s the safest and cleanest method available.
It’s the first medical cannabis producer to meet stringent pharmaceutical regulatory requirements.
As a result, this company was able to secure a deal with a nationwide retail pharmacy chain to sell its products.
This means they don’t have to set up distribution outlets like their competitors…
…because they have an established distribution chain in place from coast to coast.
This company has a big edge over its competitors — and a solid chance to become a 10-bagger. It’s perfectly positioned to become a pot stock blue chip.
Another Game-Changer We Jumped Into Early — Robotic Surgery
Today, every major hospital O.R. has either a Mazor Robotics or a Da Vinci surgical system. They’ve become a part of everyday medical practice.
Many people aren’t aware of this because these aren’t consumer products like iPhones. But they’ve made an even bigger impact considering how many lives they’ve saved.
Robotic surgery wasn’t common a few years ago. Now it’s the standard of care.
We spotted this medical revolution five years ago, in 2013. Our research led us to recommend a medical robot maker called Mazor Robotics.
It was a twelve-bagger… up 1,242%.
Brian S., from Avila Beach California wrote us after his stock made $24,000 and said, “We purchased Mazor in three accounts and all are up.” Those shares, by the way, are now worth $213,000.
Richard M., of Saugerties, New York said, “I currently hold Mazor Robotics and Gogo. On just these two stocks I’m up over $30,000.”
Ready for Stocks Picks You Won’t Get Anywhere Else?
Fast-Track Millionaire is a service for millionaires and investors who want to become millionaires.
I’m not looking for dividends. And I’m not happy with accepting 10% a year from blue chips.
I want innovators, disrupters, and better mousetrap builders.
These are the companies I look for. In fact, those are the only companies I look for.
When you find stocks like that, you don’t have to worry about corrections or bear markets.
Companies selling better mousetraps rake in revenues no matter what the market is doing.
The truth is I don’t even look for stocks at all initially. I look for ideas.
Most analysts start by going over a company’s financial filings… looking for stocks with great earnings and balance sheets. But you’ll never find huge winners that way. You have to do it the other way around.
First you find a catalyst that can upend the status quo and create an entirely new industry.
And to do that, you have to think big. You have to ask yourself, “What’s the next big thing that’s going to change the way we live our lives? What’s some scientist in a research lab working on right now that could change everything?”
And here’s the funny thing: it doesn’t have to be a scientist in a lab. It could be some bright kid in his garage, too. That’s how Steve Jobs started. Zuckerberg built Facebook from his dorm room.
I promise you, these companies are out there. You just have to think outside the box — and then do the research — to find them.
You don’t wait until it’s in the press. You have to find it before the reporters. And then you have to really get to understand it so you can tell the difference between some company’s pumped-up PR and an actual God’s-honest opportunity.
Only then do you go over the financial figures to see if the company has the resources to deliver. Not first.
If you’re reading about a breakthrough in the news, you’ve already missed the big gains.
I know I’m repeating myself, but it takes a lot of work.
It’s not always fun to spend the work week on the road investigating a corporate site… then spend the weekend at home leafing through the Journal of Molecular Biology.
But the payoff comes with winners like:
Mazor Robotics, which shot up 1,242%…
Tesla, up 1,110%…
Alnylam Pharmaceuticals, which soared 1,263%…
or Tencent Holdings that went up 1,079%…
Each of these became an industry leader, giving Fast-Track Millionaire readers the chance to multiply their money.
Want to Know More?
(There’s $10,000 Waiting for You)
If you’re interested in the Swiss gene-editing company that is poised to save millions of lives (possibly even your own), I’d love to send you my full report on it.
It comes free with my Fast-Track Millionaire service. And what’s unusual about this service is that anyone who joins is guaranteed the opportunity to collect a 100% gain.
To be specific, I promise that anyone who follows my recommendations for a full year will have at least one chance to double their money… and turn $10,000 into $20,000.
It’s not often that someone promises you $10,000.
But I’m comfortable making this promise because every company I recommend has the potential to double.
And it happens a lot…
More than 130 stocks recommended in Fast-Track Millionaire have gone up 100%… with some reaching on up to 800%, 900%, even 1,263%.
How Fast-Track Millionaire Works…
It’s pretty simple:
Once a month, I send members the most explosive opportunity I’m researching.
I include my analysis of the opportunity and its market potential. I explain why I’m excited about it… and share the full results of my research.
I give them specific instructions on how to take advantage of the situation… including my “buy up to” price and any additional instructions to maximize your gain.
I share at least one recommendation a month, sometimes more. Every one of them has explosive potential. Some could double within a year… some could take longer…and others could move even faster.
After the main issue at the start of the month, I follow it up with a mid-month update, with a recap of where our investments stand… and how the portfolio is performing.
When it’s time to sell, I notify members by email. And if they wish, by text message as well.
I’m always researching new catalysts that will spark even more opportunities.
In fact, I’m investigating a situation right now that is the next logical step after the Internet.
I’ll be sharing the details with Fast-Track Millionaire members in a few weeks, as soon as I wrap up my investigation.
Get All My Current Research Now
I’ve created in-depth reports for every opportunity I’ve mentioned today.
The first report is called Make a Million in Personalized Medicine…
…and it covers what I believe is the biggest investment opportunity we’ll see in our lifetime.
It will change the concept of what it means to be human, as we see major diseases eradicated… and as our life expectancy reaches 120 years.
I’ve been tracking this development for seven years.
Now, we’re seeing companies starting to develop cures for cancer, diabetes, blindness, and Alzheimer’s…
As these treatments become commonplace, some of these companies will grow into giants… as big as Apple, Google, Microsoft, or Amazon.
The cash going into this effort is incredible, perhaps unprecedented… because the ultimate payoff from consumers is going to be incalculably high.
There’s a limit on how much people will spend on cars, clothes, and other things… but they will spend their last dime to stay alive.
Likewise, people will shop around to save money on a new car. But they won’t skimp when it comes to this.
They will pay anything to live long enough to see their kids get married… their grandchildren graduate… and stick around for all the other milestones that make life precious.
Think about it…
In a world where people line up to drop $1,000 on a new smartphone…. imagine how much they’ll pay to live another 20, 30, 40 years.
It’s clear to me that the stock returns here will be phenomenal, along the lines of Apple and Amazon.
If you had invested $10,000 in Apple in 2003, you would have $2 million today.
$10,000 invested in Amazon would now be $5 million.
And the stock I’m picking as my #1 play on the gene-editing revolution has this same potential.
As the medical revolution takes off in the months and years ahead, I’m willing to guarantee that anyone who follows my Fast-Track Millionaire recommendations will be able to turn $10,000 into $20,000.
Genia’s Double Your Money Guarantee: Anyone who follows my recommendations in Fast-Track Millionaire will have a chance to turn every $10,000 invested into $20,000.
You get full details on this opportunity as soon as you become a Fast-Track Millionaire member.
But you need to take the first step. I can’t do it for you.
Unfortunately, I’ve found that even though most investors dream of making gains like these — few actually act on the opportunity when they see it.
I guess it’s human nature. But the truth is, you have to take that first step if you’re ever going to get anywhere.
And I invite you to do so now… and become the newest member of the Fast-Track Millionaire club.
As will be clear when you receive my work, I don’t believe there’s anyone on Wall Street who can touch our level of research.
And as you can imagine, it comes at a price. The travel costs… research materials… the hundreds of hours of investigation all add up.
To cover our costs at our current membership level, it comes to roughly $4,000 per member per year.
Considering the gains the service has delivered, it’s a fair price.
But you won’t have to pay anywhere near that price today… because my publisher is letting 250 new members join at a fraction of the regular cost.
He tells me that offering a huge first-time discount is the most effective way to get a new client.
He knows that if you try my research and it makes you money, you’ll stay with us.
But you have to try it first. So he wants to make it as easy as possible for you to give it a test run.
That’s why — in addition to today’s discount — he’s asked me to include something special for our 250 new members.
You see, sometimes I find companies that pass all my screens, but aren’t yet listed on the stock market.
For most people, there’s simply no way of investing in them.
And that’s a shame, because the returns in this private market are like nothing else on God’s green earth.
This is where companies like Pinterest started, where a $2,000 investment turned into $1.4 million…
…and GoPro, which turned $2,000 into $2.6 million…
… and Airbnb, where $2,000 became an astounding $16 million.
For almost 90 years, the SEC restricted these opportunities to high net worth “accredited” investors.
Regular people had no way of participating in them. But just recently, the SEC opened them up to everyone.
Unfortunately, most people have no idea these opportunities exist. And wouldn’t know how to invest in them even if they did know about them.
That’s why I prepared an additional report for new members called The Angel Investor’s Secret to Unlocking Early Mega-Fortunes.
Now you’ll be able to invest in these opportunities (if you choose to), whenever I find them.
Again these are not common stocks… and they aren’t available from your broker. But they are the most lucrative equities on earth by far.
You’ll get this report along with everything else we talked about today.
So let’s quickly go over everything you’ll get with your new membership:
Fast-Track Millionaire Monthly Issues
You’ll get your monthly issue of Fast-Track Millionaire with a detailed report on the most lucrative situation I can find. I’ll tell you why I’m excited about it… with specific instructions on how to take advantage of the situation… including the stock’s “buy up to” price and any additional instructions to maximize your gains.
- Separate from my recommended portfolios, I will send you short-term trades when I find a catalyst that could spark a double-digit gain within a month.
- My FTM Watch List will give you two or three promising companies that I’ve got my eye on but which just haven’t made the cut… yet. You can monitor them and become a first investor before the market gets wind of it.
- In my IPO Watch List I’ll profile companies that have recently begun trading – or are about to go public — that are worth tracking as potential investments.
- What to Sell Now – These stocks are the dogs of Wall Street — stay away at all costs.
Make a Million in Personalized Medicine
I’ll also send you my research into the profound development that will change the lives of nearly everyone alive today.
Personalized medicine is finally unlocking the key to ending disease and extending human life to 120 years of age. This report zeroes in on the crucial company working to deliver these radical changes, including its technology to shrink cancer tumors, and much more…
How to Make 1,200% as Marijuana Prohibition Ends
This report briefs you on the explosive marijuana industry… and reveals how you could multiply your money 12x in the only medical cannabis grower licensed to sell its products in a nationwide pharmacy.
With California embracing recreational sales of pot, and Canada making it totally legal, it’s going to be an exciting year for this industry. And as four additional states prepare to legalize cannabis, the opportunities are just awesome.
The Angel Investor’s Secret to Unlocking Early Mega-Fortunes
You’ll also receive an insider’s exposé on how to invest in the world’s most innovative companies ahead of other investors… before they’re listed on the stock market. This is how those incredible moonshots happen… like the $5,000 pre-IPO investment in Google that turned into $36 million.
You Get Even More With Your Membership…
Mid-Month Updates
You’ll also receive a mid-month update with a recap of where our investments stand… how the portfolio is performing… and a quick brief on any new opportunities I have uncovered.
Special Alerts
You’ll get a special alert whenever something needs immediate attention. Generally it’ll be an early notification to pocket a portion of your gains.
Text Alerts
We’ll also send you fast-action text alerts straight to your cell phone, alerting you to check your email for my latest recommendation. These alerts are purely optional, but they’re the best way to make sure you don’t miss anything important.
Members-Only Website
As soon as you join, you’ll receive a password to my private website. Here you’ll be able to access every regular issue, mid-month issue, special alert… plus every investment report and video I’ve prepared for you.
VIP Customer Service
As a Fast-Track Millionaire member, you also become part of StreetAuthority’s VIP community. That gives you direct access to me by email. You also get a dedicated Customer Service team that is on call to help you with every aspect of your membership and to answer any questions you may have.
Join Today at 50% Off
As I mentioned, if you become a Fast-Track Millionaire member today, you won’t have to pay the regular $4,000 membership fee.
We’re letting 250 people today join at a fraction of that price. Just $1,995 a year.
This is the only time we’ll offer Fast-Track Millionaire at this price. It will never be this affordable again.
And of course, we want to remove any risk for you to try our service. So we’re giving you a Double Guarantee…
Guarantee #1: 100% Satisfaction
If at any time during the first 30 days you are not completely delighted with the information, analysis, gains or anything else about Fast-Track Millionaire, simply let us know, and you’ll get a full, prompt refund. No questions asked.
That’s my satisfaction guarantee. Now here’s my performance guarantee…
Guarantee #2: My $20,000 Promise
I guarantee that anyone who joins my Fast-Track Millionaire service will have the chance to double their money within the year. $10,000 in at least one of my recommendations will turn into $20,000. If not, I’ll work another year for them free of charge.
Even if my pick turns your $10,000 into $19,999… it’s still not $20,000. And you can still claim your guarantee promise and get a second year of my service, absolutely free.
I think that’s as fair as it gets.
I don’t know any other way I could make it easier for you to get on board with us.
So go ahead and click on the button below. At a minimum you can take a look at my research on the Swiss genetic-editing stock… get the ticker symbol… and see if you agree with me that this opportunity is going to make a lot of people rich.
You’ll also get my reports (total value $225) and you can follow my research for a month — and it’s all on the house if you don’t like it.
Remember that even if you cancel your subscription, all of the information I give you — including all of my “BUY” recommendations — are yours to keep.
That’s right… you keep everything.
But you must act now…
Again, the regular price of a one-year membership in Fast-Track Millionaire is $4,000.
But when you join today you’ll get everything I’ve laid out for you… plus complete access to Fast-Track Millionaire for a full year… for just $1,995 — a fraction of the normal rate.
This is the only time we’ll offer Fast-Track Millionaire at this price. It will never be this affordable again.
I urge you to take the next step and click the button below.
You’ll be taken to another page where you’ll able to review the details of this special offer… including how you’ll be able to walk away with $20,000 in the next year.
Welcome aboard!
Genia Turanova
Chief Investment Strategist, Fast-Track Millionaire
Copyright © 2019 StreetAuthority, a division of Capitol Information Group, Inc. In order to ensure that you are utilizing the provided information and products appropriately, please review StreetAuthority’s terms and conditions and privacy policy pages.